Is Levosimendan Superior to Milrinone Regarding Acute Kidney Injury After Cardiac Surgery for Congenital Heart Disease?

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2014
The aim of the study is to assess the ability of Levosimendan to reduce the postoperative acute kidney injury in pediatric patients undergoing surgery for congenital heart disease (CHDs).
Epistemonikos ID: bb4fe2cf6519c9059d8f580286affff58cca97ed
First added on: May 12, 2024